Cerebrasol Ltd
Cerebrasol Ltd. specializes in the design and delivery of focused preclinical research packages, using electrophysiological recording techniques for nervous system indications such as pain, neurodegeneration (Alzheimer’s and Parkinson’s disease), psychiatric disorders, movement disorders and obesity. The company prepares your compounds for clinical development by providing a flexible, highly skilled service with fast turnaround tailored to clients’ needs, delivering key proof-of-concept, drug efficacy, mechanism of action data and more. For more information, visit: www.cerebrasol.com.
